ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1,4,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1,6,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
2,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3,1,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
4,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
4,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,4,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
4,5,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
4,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5,1,Laryngeal neoplasm,Laryngeal neoplasms malignancy unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5,2,Pericardial disease,Pericardial disorders NEC,Pericardial disorders,Card,N
6,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
6,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
6,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
7,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
7,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
